- Nova-Clin was founded by Dr. Cristina Igrisan and Dr. Bernhard Scheidel in 2018.
- The Nova-Clin team with Dr. Cristina Igrisan as Managing Director has successfully conducted phase I, II and III clinical trials since 2004.
- Nova-Clin is an independent clinic unit and CRO. All services can be offered without any conflicts of interest.
- Nova-Clin is authorised by the competent authority and certified according to DIN ISO 9001.
- Nova-Clin employs around 35 highly qualified and experienced staff. Together with our partner companies ACC and DELPH-i, we employ a total of about 85 staff. Our partnerships with external experts and consultants as well as our network round off our comprehensive range of services.
- Nova-Clin works worldwide for pharmaceutical companies, clinical units and specific clients of various sizes.
Nova-Clin’s Corporate Principles are simple and honest:
- High scientific and ethical quality standards
- Highly reliable
- Work on schedule
- High commitment
- Fair and efficient cost calculation